PMC:3940921 / 0-225 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3940921","sourcedb":"PMC","sourceid":"3940921","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3940921","text":"Synergistic effects of proteasome inhibitor carfilzomib in combination with tyrosine kinase inhibitors in imatinib-sensitive and -resistant chronic myeloid leukemia models Carfilzomib in imatinib-sensitive and -resistant CML ","tracks":[]}